<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2013-6609-218-13040</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Lactobacillus mediated antibody delivery in the vaginal tract for treatment of HIV</narrative>
   <narrative xml:lang="SV">Lactobacillus medierad produktion i vagina av antikroppsfragment mot HIV</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Sexual and reproductive ill-health and particularly HIV/AIDS pose serious obstacles to poverty reduction, global development and gender equality. Topical prevention strategies designed to block HIV transmission at mucosal surface represents one of the currently most promising tool for preventing this infection. A major impediment to any passive administration of microbicides is the efficient and practical delivery of the active product. The aim of this project is to develop a prophylactic therapy based on lactobacilli delivering llama single domain antibody fragments (VHH) against HIV envelope proteins in the vaginal tract. Compared to conventional antibodies, VHHs are markedly more acid resistant, easier to express in a functional recombinant form, and can more easily reach cavities in proteins due their longer CDR3 region. The genes encoding the VHHs will be cloned in lactobacilli with an ability to colonise the vaginal tract using a pharmaceutical grade and biologically contained expression system. The modified lactobacilli will subsequently be tested for safety in humans in a clinical trial. The modified lactobacilli would be lyophilised, and incorporated in tampons or capsules allowing stockpiling of a prophylactic that can be conserved for long periods of time. Administration of modified vaginal isolates of lactobacilli, expressing VHH fragments, could prevent access or entry of HIV into host cells and tissues, thereby markedly reducing the risk for infection.</narrative>
   <narrative xml:lang="SV">Sexuell/reproduktiv oh&#xE4;lsa, speciellt HIV/AIDS, leder till sv&#xE5;righeter att uppn&#xE5; m&#xE5;len f&#xF6;r fattigdomsreduktion, global utveckling och j&#xE4;mst&#xE4;lldhet mellan k&#xF6;nen. Mer &#xE4;n 25 miljoner m&#xE4;nniskor har hittills avlidit till f&#xF6;ljd av AIDS, en sjukdom som orsakas av infektion med HIV-1. Heterosexuellt &#xF6;verf&#xF6;rd smitta &#xE4;r i dagsl&#xE4;get den vanligaste formen av transmission. Utvecklandet av ett vaccin har visat sig vara oerh&#xF6;rt sv&#xE5;rt. Lokal behandling med virush&#xE4;mmande agens &#xE4;r en metod som f&#xF6;r n&#xE4;rvarande verkar vara den mest lovande som f&#xF6;rebyggande behandling mot sexuell &#xF6;verf&#xF6;ring av virus. Det st&#xF6;rsta hindret idag &#xE4;r att finna en enkel, praktisk och effektiv metod f&#xF6;r att administrera dessa medel. Vi har tidigare utvecklat metoder f&#xF6;r att f&#xE5; vanliga mj&#xF6;lksyrebakterier (lactobaciller) att producera antikroppar. Denna typ av bakterier f&#xF6;rekommer normalt i h&#xF6;g m&#xE4;ngd b&#xE5;de i tarmen och i vagina. Syftet med projektet &#xE4;r att modifiera de utvalda stammarna s&#xE5; att de producerar antikroppar mot HIV p&#xE5; cellerna som beh&#xF6;vs f&#xF6;r infektion, och att testa den profylaktiska effekten av dessa bakterier mot smitta med HIV-1. Dessa f&#xF6;rs&#xF6;k skulle kunna leda fram till en framtida behandling med frystorkade, modifierade laktobaciller som appliceras regelbundet via tamponger eller vagitorier och som skulle kunna producera ett lokalt skydd mot smitta.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Karolinska Institutet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-01-01" type="1"></activity-date>
  <activity-date iso-date="2014-01-01" type="3"></activity-date>
  <activity-date iso-date="2016-12-31" type="2"></activity-date>
  <activity-date iso-date="2016-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ZA" percentage="100">
   <narrative xml:lang="EN">South Africa</narrative>
  </recipient-country>
  <sector code="130" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Population Policies/Programmes &amp; Reproductive Health</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">214288.8380297089</value>
  </budget>
  <budget>
   <period-start iso-date="2015-01-01"></period-start>
   <period-end iso-date="2015-12-28"></period-end>
   <value currency="USD" value-date="2015-01-01">134412.110139632</value>
  </budget>
  <budget>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">132413.9543037457</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-11-07"></transaction-date>
   <value currency="USD" value-date="2013-11-07">573604.3726586009</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">214288.8380297089</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-01-28"></transaction-date>
   <value currency="USD" value-date="2015-01-28">134411.1610691279</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-28"></transaction-date>
   <value currency="USD" value-date="2016-01-28">132413.9543037457</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://upload.openaid.se/document/ingen-myndighet-vald/generella-bidragsvillkor-2014.pdf">
   <title>
    <narrative xml:lang="SV">Generella bidragsvillkor 2014</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
